I
Infinity Pharmaceuticals
Biotech & Life Sciences · Cambridge, United States · Founded 2001 · IPO 2009
Discovery and development of medicines for the treatment of cancer and related conditions MoreLess
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. The company primarily targets the immune system to treat advanced melanoma and other malignancies. Operating in the biotechnology sector, Infinity Pharmaceuticals serves patients with severe cancer conditions, collaborating with leading medical institutions and researchers. The company’s business model revolves around the research, development, and commercialization of novel drugs. Revenue is generated through the sale of approved therapies and partnerships with other pharmaceutical companies. Infinity Pharmaceuticals leverages its scientific expertise and strategic collaborations to advance its drug pipeline, aiming to bring life-saving treatments to market.
Keywords: biopharmaceutical, cancer therapies, immune system, advanced melanoma, biotechnology, drug development, commercialization, strategic collaborations, novel drugs, life-saving treatments.
Talent graph
Infinity Pharmaceuticals's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Infinity Pharmaceuticals has talent and traffic
team presence
Market sentiment
What the market is saying about Infinity Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Infinity Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Infinity Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.